ONCBeOne Medicines AG

$354.29+5.9% 1Y

Is the business good?

Mixed

The checks split: nothing decisive, though margins widening.

1 good, 1 neutral, 2 without data
Margin direction, 3 years+123.8 pts

Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.

Where ROE comes from2% ROA

A balanced mix of margins, efficiency, and leverage. ROE 4% = margin × turnover × leverage.

All from derived.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.